The U.S. Food and Drug Administration on Monday announced the launch of a new generative AI technology that agency leaders said will help its employees do their jobs more efficiently.

WHY IT MATTERS

The tool, called Elsa, is meant to "modernize agency functions," according to FDA officials, and make use of AI capabilities to drive efficiencies and "better serve the American people."

The large language model-powered tech can help summarize adverse events to support safety profile assessments, perform faster label comparisons and generate code to help develop databases for nonclinical applications, according to the FDA.

The agency had already been using the genAI tool to help streamline clinical protocol reviews and reduce the time needed for scientific evaluations and the identification

See Full Page